 | • レポートコード：QYR9ST04730 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、膀胱がん治療の世界市場について調査・分析し、膀胱がん治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（移行上皮膀胱がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮膀胱がん、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膀胱がん治療市場動向 ・主要企業別マーケットシェア ・膀胱がん治療の種類別市場規模2014-2019 （移行上皮膀胱がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮膀胱がん、その他） ・膀胱がん治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・膀胱がん治療の北米市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療の中国市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療の日本国内市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療のインド市場：主要企業・種類別/用途別市場規模 ・膀胱がん治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb、Eli Lilly、F. Hoffman-La Roche、Pfizer） ・膀胱がん治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost layer called urothelium or transitional epithelium, composed of epithelium or transitional cells.The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This in turn, will help in avoiding side effects of these drugs on healthy cells. With a better understanding of tumor immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma. One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.
In 2018, the global Bladder Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bladder Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bladder Cancer Therapeutics development in United States, Europe and China.
The key players covered in this study
Bristol-Myers Squibb
Eli Lilly
F. Hoffman-La Roche
Pfizer
…
Market segment by Type, the product can be split into
Transitional Cell Bladder Cancer
Invasive Bladder Cancer
Superficial Bladder Cancer
Squamous Cell Bladder Cancer
Others
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bladder Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Bladder Cancer Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bladder Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bladder Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Transitional Cell Bladder Cancer
1.4.3 Invasive Bladder Cancer
1.4.4 Superficial Bladder Cancer
1.4.5 Squamous Cell Bladder Cancer
1.4.6 Others
1.5 Market by Application
1.5.1 Global Bladder Cancer Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bladder Cancer Therapeutics Market Size
2.2 Bladder Cancer Therapeutics Growth Trends by Regions
2.2.1 Bladder Cancer Therapeutics Market Size by Regions (2014-2025)
2.2.2 Bladder Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bladder Cancer Therapeutics Market Size by Manufacturers
3.1.1 Global Bladder Cancer Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Bladder Cancer Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bladder Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Bladder Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Bladder Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Bladder Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bladder Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Bladder Cancer Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Bladder Cancer Therapeutics Market Size (2014-2019)
5.2 Bladder Cancer Therapeutics Key Players in United States
5.3 United States Bladder Cancer Therapeutics Market Size by Type
5.4 United States Bladder Cancer Therapeutics Market Size by Application
6 Europe
6.1 Europe Bladder Cancer Therapeutics Market Size (2014-2019)
6.2 Bladder Cancer Therapeutics Key Players in Europe
6.3 Europe Bladder Cancer Therapeutics Market Size by Type
6.4 Europe Bladder Cancer Therapeutics Market Size by Application
7 China
7.1 China Bladder Cancer Therapeutics Market Size (2014-2019)
7.2 Bladder Cancer Therapeutics Key Players in China
7.3 China Bladder Cancer Therapeutics Market Size by Type
7.4 China Bladder Cancer Therapeutics Market Size by Application
8 Japan
8.1 Japan Bladder Cancer Therapeutics Market Size (2014-2019)
8.2 Bladder Cancer Therapeutics Key Players in Japan
8.3 Japan Bladder Cancer Therapeutics Market Size by Type
8.4 Japan Bladder Cancer Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bladder Cancer Therapeutics Market Size (2014-2019)
9.2 Bladder Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Bladder Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Bladder Cancer Therapeutics Market Size by Application
10 India
10.1 India Bladder Cancer Therapeutics Market Size (2014-2019)
10.2 Bladder Cancer Therapeutics Key Players in India
10.3 India Bladder Cancer Therapeutics Market Size by Type
10.4 India Bladder Cancer Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Bladder Cancer Therapeutics Market Size (2014-2019)
11.2 Bladder Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Bladder Cancer Therapeutics Market Size by Type
11.4 Central & South America Bladder Cancer Therapeutics Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bladder Cancer Therapeutics Introduction
12.1.4 Bristol-Myers Squibb Revenue in Bladder Cancer Therapeutics Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bladder Cancer Therapeutics Introduction
12.2.4 Eli Lilly Revenue in Bladder Cancer Therapeutics Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 F. Hoffman-La Roche
12.3.1 F. Hoffman-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bladder Cancer Therapeutics Introduction
12.3.4 F. Hoffman-La Roche Revenue in Bladder Cancer Therapeutics Business (2014-2019)
12.3.5 F. Hoffman-La Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bladder Cancer Therapeutics Introduction
12.4.4 Pfizer Revenue in Bladder Cancer Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bladder Cancer Therapeutics Key Market Segments
Table Key Players Bladder Cancer Therapeutics Covered
Table Global Bladder Cancer Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Type 2014-2025
Figure Transitional Cell Bladder Cancer Figures
Table Key Players of Transitional Cell Bladder Cancer
Figure Invasive Bladder Cancer Figures
Table Key Players of Invasive Bladder Cancer
Figure Superficial Bladder Cancer Figures
Table Key Players of Superficial Bladder Cancer
Figure Squamous Cell Bladder Cancer Figures
Table Key Players of Squamous Cell Bladder Cancer
Figure Others Figures
Table Key Players of Others
Table Global Bladder Cancer Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Bladder Cancer Therapeutics Report Years Considered
Table Global Bladder Cancer Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Bladder Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bladder Cancer Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Bladder Cancer Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Bladder Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Bladder Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Bladder Cancer Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Bladder Cancer Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bladder Cancer Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Bladder Cancer Therapeutics Market Share by Manufacturers in 2018
Table Global Bladder Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bladder Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Bladder Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Bladder Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Bladder Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Bladder Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Bladder Cancer Therapeutics Revenue Market Share by Application in 2018
Figure United States Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table United States Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table United States Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure Europe Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table Europe Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table Europe Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure China Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table China Bladder Cancer Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table China Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure Japan Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table Japan Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table Japan Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure India Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table India Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table India Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Bladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bladder Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Bladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bladder Cancer Therapeutics Market Share by Type (2014-2019)
Table Central & South America Bladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bladder Cancer Therapeutics Market Share by Application (2014-2019)
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Bladder Cancer Therapeutics Business (2014-2019) (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Bladder Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Bladder Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Bladder Cancer Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table F. Hoffman-La Roche Company Details
Table F. Hoffman-La Roche Revenue in Bladder Cancer Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffman-La Roche Revenue Growth Rate in Bladder Cancer Therapeutics Business (2014-2019)
Table F. Hoffman-La Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Bladder Cancer Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Bladder Cancer Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Global Bladder Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Bladder Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Bladder Cancer Therapeutics Market Size Share by Regions in 2025
Figure United States Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Bladder Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Bladder Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Bladder Cancer Therapeutics Market Size by Product in 2025
Table Global Bladder Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Bladder Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Bladder Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
膀胱がん臨床試験の世界市場：市場規模・現状・予測 Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearb…- 非小細胞肺癌治療薬の世界市場：市場規模・現状・予測 Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a r…
- 小細胞肺がん治療薬の世界市場：市場規模・現状・予測 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 世界のハンドヘルド膀胱スキャナー市場：専門的調査 A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. The global Handheld Bladder Scanners market was valued at xx million U…
- 世界のベンチトップ膀胱スキャナー市場：専門的調査 A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. The global Benchtop Bladder Scanners market was valued at xx million U…